← SynDRA

ESREBOXETINE

SynDRA canonical compound SYN0005594 — structure-anchored drug synonym record

All known targets

• SLC6A2

Mechanisms of action (all sources)

• Adrenergic receptor antagonist
• SLC6A2 BLOCKER

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

• CP3A4
• CYP2D6
• MAPT
• SC6A2
• SLC6A4

Cross-references

• PubChem CID: 65856
• ChEMBL: CHEMBL180101
• DrugBank: DB12395
• ChEBI: 125535
• KEGG: D09340
• RxNorm: 60841
• PDB: A1D9Y
• Wikipedia: Esreboxetine
• TTD: D01NJT
• LINCS BRD: BRD-M39350793

Synonyms

• Esreboxetina
• (s,s)-reboxetine
• S,s-reboxetine
• Ss-rbx
• (S,S)-RBX
• REBOXETINE
• (S,S)-reboxetine
• UNII-L8S50ZY490
• PNU 165442g
• L8S50ZY490
• Norebox
• Davedax
• Solvex
• (2S)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine
• (2S)-2-[(S)-2-ethoxyphenoxy(phenyl)methyl]morpholine
• (2S)-2-[(S)-(2-ethoxyphenoxy)-phenyl-methyl]morpholine
• Prolift
• Esreboxetine [USAN:INN]
• Esreboxetine (USAN/INN)
• (S,S)-( )-Reboxetine
• S-Reboxetine
• 2-((2-ethoxyphenoxy)benzyl)morpholine methanesulfonate
• Tocris-1982
• NCGC00025335-01
• SCHEMBL34534
• Reboxetine mesylate
• (+-)-(2R*)-2-((alphaR*)-alpha-(o-Ethoxyphenoxy)benzyl)morpholine
• reboxetine
• S,S-reboxetine
• (S,S)-(+)-Reboxetine
• (+)-(2S)-2-((S)-(2-Ethoxyphenoxy)phenylmethyl)morpholine
• [S,S]-RBX
• esreboxetinum
• RefChem:591145
• DTXCID601436369
• PNU-165442G
• SS-RBX
• (S)-2-((S)-(2-ethoxyphenoxy)(phenyl)methyl)morpholine
• Morpholine, 2-((S)-(2-ethoxyphenoxy)phenylmethyl)-, (2S)-